MEDNYSEMiscellaneous Food Preparations & Kindred ProductsUS GAAP · USD

MEDIFAST INC

Medifast is a U.S. health and wellness company built around its OPTAVIA coach-guided lifestyle system, which combines structured nutrition products with personalized coaching and community support. The company is repositioning itself from traditional weight management toward broader metabolic health, using science-backed programs, digital tools, and an independent coach network to drive customer acquisition and retention.

Liikevaihto386milj. USD
−36,0 %v/v
Liikevoitto (EBIT)−14,2milj. USD
−593,8 %v/v
EBIT-marginaali−3,7%
−4,2 %-yks.v/v
Nettotulos−18,7milj. USD
−993,0 %v/v
Vapaa kassavirta1,2milj. USD
−92,7 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−50005001 0001 5002 000milj. USD2020: 935 milj. USD2020: EBIT 134 milj. USD20202021: 1 526 milj. USD2021: EBIT 216 milj. USD20212022: 1 599 milj. USD2022: EBIT 185 milj. USD20222023: 1 072 milj. USD2023: EBIT 126 milj. USD20232024: 602 milj. USD2024: EBIT 2,9 milj. USD20242025: 386 milj. USD2025: EBIT −14 milj. USD2025386−14
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Nutrition products96 %

Packaged weight-management and healthy-living foods sold through the OPTAVIA system.

Coach-guided programs2 %

Structured lifestyle plans and coaching support that help clients follow the program.

Subscription and auto-ship services1 %

Recurring ordering programs such as Premier+ that support retention and predictable ordering.

Digital coach tools and support1 %

Technology and administrative tools that help coaches manage clients and grow their businesses.

Asiakkaat

Medifast sells primarily to individual consumers seeking weight loss, weight management, and broader metabolic health solutions. Its core buying relationship is mediated by independent OPTAVIA coaches, who market the products to friends, family, and community networks and provide the behavioral support that drives repeat purchases. The company is also increasingly targeting customers using GLP-1 medications or transitioning off them, as well as people looking for a structured lifestyle program rather than a standalone diet product.

Weight loss and weight management consumers

Buy meal replacements and program support to lose weight through a structured plan.

Metabolic health clients

Buy the broader OPTAVIA system to improve metabolic health and sustain habits.

GLP-1 medication users

Buy support products and coaching to complement or manage their GLP-1 journey.

Transitioning GLP-1 users

Buy programs to maintain results and support behavior change after medication use.

Independent coaches

Participate as distributors/marketers and buy into the system to build their own businesses.

Strategia

Medifast is shifting from a transformation phase to execution, aiming to broaden its addressable market from structured weight loss into metabolic health. The company is investing in coach productivity, digital tools, and refreshed programs like Premier+ to improve acquisition, retention, and the economics of its independent coach network.

Grow the coach network and improve coach productivityLyhyt aikaväli

The coach base is the main acquisition engine, so more productive coaches should drive more clients and repeat orders.

Broaden the brand into metabolic healthKeskipitkä aikaväli

A wider health positioning can reduce dependence on traditional diet cycles and expand the addressable market.

Strengthen retention through product and program designLyhyt aikaväli

Recurring orders and client retention are critical in a coach-led model with seasonal demand swings.

Maantiede

Medifast is headquartered in the United States and its business is primarily U.S.-centric, with product sales and coach activity concentrated in the domestic market. The company also operates through subsidiaries in Hong Kong and Shanghai, indicating some Asia-related operational presence, but the filings provided do not disclose a country revenue split. Its supply chain and coach network are exposed to inflation, tariffs, and other macroeconomic pressures across the markets where it operates.

Riskit

Medifast faces intense competition from weight-loss medications, digital wellness platforms, and other nutrition brands, which can pressure demand, pricing, and customer retention. Its model also depends heavily on independent coaches and third-party manufacturing/distribution, so any decline in coach engagement, supply disruption, product quality issue, or regulatory change could materially affect results.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Competition from GLP-1 medications and wellness platforms1Dependence on independent coaches2Product liability and recall exposure3Inflation and tariff pressure4Third-party manufacturing and logistics reliance5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Competition from GLP-1 medications and wellness platformsVaikutus: KorkeaTodennäköisyys: Korkea

    Easier-to-use weight-loss drugs and digital alternatives can reduce demand for Medifast's products and coaching model.

    Kohdistuu: Core weight-management demand

  2. Dependence on independent coachesVaikutus: KorkeaTodennäköisyys: Korkea

    The coach network is the main marketing and acquisition engine, so lower coach counts directly reduce sales.

    Kohdistuu: Client acquisition and retention

  3. Product liability and recall exposureVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Food and ingestible products can trigger claims if contamination, labeling, or injury issues arise.

    Kohdistuu: Manufactured nutrition products

  4. Inflation and tariff pressureVaikutus: KeskitasoTodennäköisyys: Korkea

    Higher ingredient, freight, and import costs can compress margins and weaken consumer spending.

    Kohdistuu: Cost of sales and demand

  5. Third-party manufacturing and logistics relianceVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Supply interruptions or quality failures could hurt revenue, reputation, and product availability.

    Kohdistuu: Product supply chain

Kirjanpito

Harkinnanvaraiset erät
Point-in-time revenue recognition

Revenue is booked when products are delivered to the carrier, so shipment timing affects quarterly results.

Vaikutus: Can shift revenue between periods

Returns, rebates, and loyalty program estimates

Management must estimate deductions from gross sales, which affects net revenue and margins.

Vaikutus: Affects reported revenue and gross profit

Seasonality

Holiday-quarter weakness and early-year strength can distort sequential comparisons.

Vaikutus: Quarterly revenue and operating margin volatility

Long-lived asset impairment

Management must test assets when conditions change, and weak demand could trigger charges.

Vaikutus: Potential non-cash impairment expense

Income tax estimates and uncertain tax positions

Tax expense depends on valuation allowances and uncertain positions that require judgment.

Vaikutus: Can affect effective tax rate and net income

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026